Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

One-Compartment Open Model for IV Bolus Administration: General Considerations01:19

One-Compartment Open Model for IV Bolus Administration: General Considerations

213
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
213
One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution01:09

One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution

278
The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
278
Two-Compartment Open Model: IV Bolus Administration01:18

Two-Compartment Open Model: IV Bolus Administration

541
The two-compartment model for intravenous (IV) bolus administration illustrates drug distribution in the body, subdividing it into central and peripheral compartments. This model operates on the concept of two-compartment kinetics. The drug's plasma concentration shows a bi-exponential decline following IV bolus administration, signaling the presence of two disposition processes: distribution and elimination.
The disparity between drug input and the sum of drug transfer rates between...
541
Two-Compartment Open Model: IV Infusion01:15

Two-Compartment Open Model: IV Infusion

245
A two-compartment model is a vital tool in pharmacokinetics, providing an essential understanding of drug behavior, especially for those administered via zero-order intravenous infusion. This model outlines two compartments: the central compartment, where elimination occurs, and the peripheral compartment.
The model illustrates the decrease in plasma drug concentration from the central compartment with a specific equation. It shows that under steady-state conditions, the drug's input rate...
245
Compartment Models: Single-Compartment Model01:14

Compartment Models: Single-Compartment Model

2.3K
The single-compartment model serves as a simplified representation of the human body. This model assumes that the body functions as a single, well-mixed open compartment. When a drug is administered intravenously, it enters the body and quickly distributes uniformly. The drug then undergoes biotransformation and elimination, ultimately leaving the body. The volume of this compartment is referred to as the apparent volume of distribution into which the drug can uniformly distribute. In this...
2.3K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

266
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
266

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Quantifying the benefits of improved operations for polio outbreak response: A model-based analysis.

Vaccine·2026
Same author

Global cessation of bivalent oral polio vaccine (bOPV): A comprehensive review of modeling studies from 2000 to 2025.

Vaccine·2026
Same author

Indirect Effects in Health Economic Models of Vaccines: Should We Include Them, and How Do We Model Them?

Applied health economics and health policy·2026
Same author

Variation in COVID-19 vaccination and adverse outcomes: a state of Georgia case study.

BMC public health·2025
Same author

Safety, tolerability, and immunogenicity of an adult-specific pneumococcal conjugate vaccine, V116, in people living with HIV (STRIDE-7): a two-part, parallel-group, randomised, active comparator-controlled, international, phase 3 trial.

The lancet. HIV·2025
Same author

A phase 3 randomized, double-blind clinical study to evaluate the safety and immunogenicity of V116 when administered concomitantly with influenza vaccine in adults 50 years of age or older.

Vaccine·2025

相关实验视频

Updated: Jul 10, 2025

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
13:53

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

5.0K

一种混合整数编程模型,用于在集团采购组织内定价疫苗.

Zhuoting Yu1, Pinar Keskinocak1, Walter A Orenstein2

  • 1H. Milton Stewart School of Industrial and Systems Engineering, Georgia Tech, 755 Ferst Drive NW, Atlanta, GA 30332, United States of America.

Vaccine
|November 17, 2023
PubMed
概括

阶级定价模型可以减少医疗产品成本的差异,以满足不同买家群体的需求. 价格层的最佳数量取决于买方的能力和支付意愿,正如疫苗采购案例研究所显示的那样.

关键词:
在定价方面公平.集团采购 集团采购 集团采购阶级定价是指阶级定价.统一的定价方式 统一的定价方式疫苗采购采购 疫苗采购采购

更多相关视频

Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application
04:24

Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application

Published on: June 16, 2023

1.5K
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.2K

相关实验视频

Last Updated: Jul 10, 2025

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
13:53

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes

Published on: December 19, 2020

5.0K
Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application
04:24

Author Spotlight: Advancing Biotherapeutic Mass Calculation by Introducing mAbScale, a Python-Based Desktop Application

Published on: June 16, 2023

1.5K
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.2K

科学领域:

  • 卫生经济学 卫生经济学
  • 制药物价格的定价方式
  • 全球卫生公平性全球卫生公平性

背景情况:

  • 获取拯救生命的药物需要平衡可负担性和健康结果.
  • 集团采购组织可以降低平均价格,但在设定个人成员价格方面也会带来挑战.
  • 买家之间的能力和支付意愿的差异使得聚合采购的价格设定变得复杂.

研究的目的:

  • 开发和评估一个模型,为医疗产品设定分层价格,以满足买家群体的需求.
  • 量化统一,分层和差异化定价制度的表现.
  • 分析在采购中的慈善支持的补贴分配模式.

主要方法:

  • 使用混合整数编程模型,根据买方的能力和支付意愿优化定价.
  • 该模型旨在最大限度地减少调整后的单位价格差异,价格根据支付能力而下降.
  • 用Gavi和PAHO采购巴西路斯卡尔梅特-格林 (BCG) 疫苗的案例研究作为说明.

主要成果:

  • 调整后的单位价格差异随着价格层数量的增加而减少.
  • 从统一定价到双层定价时,价格差异显著减少.
  • 在Gavi集团中,分层定价更有效,因为支付能力和支付意愿之间的相关性更高.

结论:

  • 该研究提出了一种定量模型,用于组采购的定价和补贴分配.
  • 阶级定价的表现取决于买方特定的因素,例如支付差距的能力和意愿.
  • 这些发现为优化全球卫生倡议中的采购策略提供了洞察力.